|Print Page | Close Window|
Creating Long-Term Shareholder Value
Medtronic is uniquely positioned to create long-term value in healthcare. The combination of Medtronic and Covidien creates a robust, market-leading medical technology and services company with a comprehensive product portfolio, broad geographic reach, and diversified growth profile. We believe Covidien meaningfully complements and accelerates our three primary strategies - therapy innovation, globalization, and economic value. We are focused on delivering a strong launch cadence of leading healthcare innovation, addressing the inequity in healthcare access globally, and becoming a leader in the changing value-based healthcare landscape with offerings that deliver both clinical and economic value to a broader set of partners around the world, including physicians, hospital systems, payers, governments, and patients. The addition of Covidien is expected to not only strengthen our long-term market competitiveness, but also increase our financial strength and capital deployment flexibility, driving further sustainability and consistency in our long-term performance. We believe that execution and reliable performance, combined with our disciplined allocation of capital, will create long-term value for our shareholders.
Sustainability Index Endorsements
Read more about our Sustainability efforts.Read more
AdvaMed’s Lifetime Achievement Award tribute to Medtronic founder Earl Bakken.PLAY VIDEO
Focus on Patients
The personal connection between Medtronic plc, its employees and patients.PLAY VIDEO